Ishizawa Keisuke, Komori Takashi, Aihara Yasuo, Maruyama Takashi, Okada Yoshikazu, Ikuta Satoko, Muragaki Yoshihiro, Hirose Takanori, Homma Taku, Sasaki Atsushi
Department of Pathology, Saitama Medical University, Saitama 350-0495, Japan.
Clin Neuropathol. 2012 May-Jun;31(3):146-51. doi: 10.5414/np300445.
Ependymomas comprise WHO Grade (G) II tumors (ependymomas) and WHO Grade III tumors (anaplastic ependymomas). Clear cell ependymoma, a subtype of ependymoma characterized by proliferation of clear cells, generally corresponds to WHO Grade III. On the other hand, clear cells are common in otherwise conventional ependymomas. This study aims to reveal the direct relationship between clear cells and proliferative activity in ependymomas. A total of 14 ependymomas with clear cells, comprising 6 WHO Grade II tumors and 8 Grade III tumors, were studied. The sections were stained with hematoxylin and eosin (H&E), and also immunostained with PHH3, a marker of mitosis, and MIB-1, an anti-Ki-67 antibody. Each case was assessed on H&E sections for necrosis and microvascular proliferation, and semi-quantified for clear cells in an increasing order as Grades I - III (clear cell grade). Mitoses were counted on H&E and PHH3-stained sections, under a light microscope, in 4 areas showing a high amount of mitosis. The MIB-1 index was manually determined on 4 images captured from the area showing the highest amount of Ki-67-positive nuclei. The results were as follows: 1) Necrosis or microvascular proliferation was present irrespective of the clear cell grade (amount of clear cells). 2) A higher amount of clear cells was associated with a higher proliferative activity. These results indicate that clear cells could be an independent prognostic factor other than necrosis, microvascular proliferation, or the WHO grade. It seems important to assess clear cells, apart from the concept of clear cell ependymoma, when diagnosing an ependymoma.
室管膜瘤包括世界卫生组织(WHO)二级肿瘤(室管膜瘤)和WHO三级肿瘤(间变性室管膜瘤)。透明细胞室管膜瘤是室管膜瘤的一种亚型,其特征为透明细胞增殖,通常相当于WHO三级。另一方面,透明细胞在其他常规室管膜瘤中也很常见。本研究旨在揭示室管膜瘤中透明细胞与增殖活性之间的直接关系。共研究了14例含有透明细胞的室管膜瘤,其中包括6例WHO二级肿瘤和8例三级肿瘤。切片用苏木精和伊红(H&E)染色,还用有丝分裂标记物PHH3和抗Ki-67抗体MIB-1进行免疫染色。对每例病例的H&E切片评估坏死和微血管增殖情况,并将透明细胞按I - III级(透明细胞分级)递增顺序进行半定量。在光学显微镜下,在4个有大量有丝分裂的区域,对H&E和PHH3染色切片上的有丝分裂进行计数。在从显示最高数量Ki-67阳性核的区域捕获的4张图像上手动确定MIB-1指数。结果如下:1)无论透明细胞分级(透明细胞数量)如何,均存在坏死或微血管增殖。2)透明细胞数量较多与较高的增殖活性相关。这些结果表明,透明细胞可能是除坏死、微血管增殖或WHO分级之外的一个独立预后因素。在诊断室管膜瘤时,除了透明细胞室管膜瘤的概念外,评估透明细胞似乎也很重要。